Incyte strikes up to $2 billion deal for Star Therapeutics' subsidiary
08/06/2026 12:03
Incyte strikes up to $2 billion deal for Star Therapeutics' subsidiary June 8 (Reuters) - Incyte INCY said on Monday it has agreed to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, in a deal worth up to $2 billion, expanding its pipeline for blood disorder therapies.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed and Vijay Kishore)
Recent news on Incyte
See all newsIncyte Corp reports results for the quarter ended September 30 - Earnings Summary
Incyte Q3 adjusted loss per share beats estimates
Revolution Medicines falls after Incyte posts competitive pancreatic cancer data
Factbox: Pharma sector doubles down on AI to slash costs, timelines
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler